SCHEMBL4754706

SCHEMBL4754706

COc1cccc(-c2cnn3c(N)c(-c4cccc(Cl)c4)c(CN4CCNCC4)nc23)c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.43
RET P07949 6/20 0.41
KIF5B P33176 6/20 0.41
KDR P35968 5/20 0.41
ETV6 P41212 5/20 0.41
CCDC6 Q16204 4/20 0.41
HTR7 P34969 2/20 0.39
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
TGFBR1 P36897 1/20 0.37
ACVR1 Q04771 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 2/20 0.36
ABL1 P00519 1/20 0.36
LCK P06239 1/20 0.36
NPM1 P06748 1/20 0.36
CSF1R P07333 1/20 0.36
LYN P07948 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167662 0.88 FYN (0.59) FYNRETKIF5BKDRETV6
SCHEMBL4695327 0.79 RET (0.43) FYNRETKIF5BKDRETV6
SCHEMBL4757041 0.77 FYN (0.53) FYNRETKIF5BKDRETV6
SCHEMBL4695372 0.76 RET (0.55) FYNRETKIF5BKDRETV6
SCHEMBL4173163 0.76 FYN (0.47) FYNRETKIF5BKDRETV6
SCHEMBL4178858 0.73 FYN (0.57) FYNRETKIF5BKDRETV6
SCHEMBL4695093 0.73 FYN (0.68) FYNRETKIF5BKDRETV6
SCHEMBL4171927 0.72 FYN (0.67) FYNRETKIF5BKDRETV6
SCHEMBL4756311 0.70 RET (0.47) FYNRETKIF5BKDRETV6
SCHEMBL4179850 0.69 FYN (0.71) FYNRETKIF5BKDRETV6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993552-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS Novartis AG (CH) 2008-11-26 EP disclosed
WO-2007103432-A9 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2008-01-10 WO disclosed
WO-2007103432-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2007-09-13 WO disclosed